Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concurrent isolated IgG2-positive membranous nephropathy and malignant B-cell lymphoma.
Shimada S, Nakamichi T, Yamada G, Narumi K, Usubuchi H, Yamamoto T, Ichikawa S, Fukuhara N, Miyazaki M, Harigae H, Sato H, Ito S. Shimada S, et al. Among authors: ichikawa s. CEN Case Rep. 2018 Nov;7(2):248-252. doi: 10.1007/s13730-018-0336-z. Epub 2018 May 15. CEN Case Rep. 2018. PMID: 29766466 Free PMC article.
γδ T cell clonal proliferation early after PD-1 blockade.
Ono K, Onishi Y, Kobayashi M, Hatta S, Nasu K, Watanabe S, Ichikawa S, Okitsu Y, Fukuhara N, Harigae H. Ono K, et al. Among authors: ichikawa s. Ann Hematol. 2019 Jan;98(1):219-220. doi: 10.1007/s00277-018-3406-6. Epub 2018 Jun 26. Ann Hematol. 2019. PMID: 29946908 No abstract available.
Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia.
Ochi T, Onishi Y, Nasu K, Onodera K, Kobayashi M, Ichikawa S, Fujiwara T, Fukuhara N, Yamada-Fujiwara M, Harigae H. Ochi T, et al. Among authors: ichikawa s. Biol Blood Marrow Transplant. 2019 Feb;25(2):e55-e59. doi: 10.1016/j.bbmt.2018.09.039. Epub 2018 Oct 4. Biol Blood Marrow Transplant. 2019. PMID: 30292011 Free article. Clinical Trial.
Preemptive therapy for cytomegalovirus reactivation after daratumumab-containing treatment in patients with relapsed and refractory multiple myeloma.
Nakagawa R, Onishi Y, Kawajiri A, Onodera K, Furukawa E, Sano S, Saito K, Ichikawa S, Fujiwara T, Fukuhara N, Harigae H. Nakagawa R, et al. Among authors: ichikawa s. Ann Hematol. 2019 Aug;98(8):1999-2001. doi: 10.1007/s00277-019-03645-7. Epub 2019 Mar 1. Ann Hematol. 2019. PMID: 30824957 No abstract available.
1,170 results